Chen Jiang

5.7k total citations · 2 hit papers
112 papers, 4.5k citations indexed

About

Chen Jiang is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Chen Jiang has authored 112 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 39 papers in Biomaterials and 38 papers in Biomedical Engineering. Recurrent topics in Chen Jiang's work include Nanoplatforms for cancer theranostics (36 papers), Nanoparticle-Based Drug Delivery (31 papers) and Immune cells in cancer (13 papers). Chen Jiang is often cited by papers focused on Nanoplatforms for cancer theranostics (36 papers), Nanoparticle-Based Drug Delivery (31 papers) and Immune cells in cancer (13 papers). Chen Jiang collaborates with scholars based in China, South Korea and Portugal. Chen Jiang's co-authors include Yifei Lü, Tao Sun, Liang Han, Qinjun Chen, Zhen Gu, Quanyin Hu, Peixin Liu, Yujie Zhang, Xi He and Qin Guo and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Nano Letters.

In The Last Decade

Chen Jiang

104 papers receiving 4.4k citations

Hit Papers

In situ sprayed bioresponsive immunotherapeutic gel for p... 2018 2026 2020 2023 2018 2025 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chen Jiang China 32 2.0k 1.7k 1.5k 862 594 112 4.5k
Tao Sun China 38 2.0k 1.0× 2.0k 1.2× 1.8k 1.2× 769 0.9× 729 1.2× 130 5.0k
Qingxiang Song China 39 1.7k 0.8× 2.2k 1.3× 1.8k 1.2× 610 0.7× 393 0.7× 67 4.5k
Hongliang Xin China 32 1.5k 0.8× 1.6k 1.0× 1.8k 1.2× 441 0.5× 380 0.6× 65 3.9k
Song Shen China 39 2.4k 1.2× 2.2k 1.3× 1.6k 1.0× 1.2k 1.4× 556 0.9× 82 5.0k
Qinjun Chen China 31 1.4k 0.7× 1.1k 0.7× 907 0.6× 469 0.5× 762 1.3× 87 3.2k
Jie Gao China 43 1.8k 0.9× 2.9k 1.7× 1.7k 1.1× 689 0.8× 586 1.0× 238 6.4k
Chen Jiang China 41 1.9k 0.9× 3.2k 2.0× 2.3k 1.6× 450 0.5× 579 1.0× 78 5.8k
Yujie Zhang China 29 1.4k 0.7× 1.1k 0.7× 1.2k 0.8× 380 0.4× 384 0.6× 84 3.1k
Jiangbing Zhou United States 37 1.1k 0.5× 2.6k 1.6× 1.2k 0.8× 323 0.4× 451 0.8× 78 4.7k

Countries citing papers authored by Chen Jiang

Since Specialization
Citations

This map shows the geographic impact of Chen Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen Jiang more than expected).

Fields of papers citing papers by Chen Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chen Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen Jiang. The network helps show where Chen Jiang may publish in the future.

Co-authorship network of co-authors of Chen Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Chen Jiang. A scholar is included among the top collaborators of Chen Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chen Jiang. Chen Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
He, Jiahui, et al.. (2025). Brain-targeting peptide-functionalized nanomicelles for enhanced vancomycin delivery and meningitis therapy. Chemical Engineering Journal. 521. 167028–167028.
3.
Chen, Hongyi, Haolin Song, Chufeng Li, et al.. (2025). Cascade‐Targeted Nanoparticles for Enhanced Gemcitabine Delivery and Adenosine Metabolism Modulation to Overcome Treatment Resistance in Pancreatic Cancer. Advanced Science. 12(38). e07118–e07118. 2 indexed citations
4.
Zhang, Tongyu, Peixin Liu, Wei Shen, et al.. (2025). DNase I‐Mediated Chemotactic Nanoparticles for NETs Targeting and Microenvironment Remodeling Treatment of Acute Ischemic Stroke. Advanced Science. 12(34). e03689–e03689. 7 indexed citations
5.
Zhou, Zheng, Haoyu You, Boyu Su, et al.. (2025). Multiple‐Stimuli‐Responsive Biomimetic Polypyrrole Delivery System for Synergistic Regulation and Restoration of Epileptic Foci. Advanced Functional Materials. 35(50).
6.
You, Haoyu, Shilin Zhang, Yiwen Zhang, et al.. (2025). Engineered Bacterial Outer Membrane Vesicles‐Based Doxorubicin and CD47‐siRNA Co‐Delivery Nanoplatform Overcomes Immune Resistance to Potentiate the Immunotherapy of Glioblastoma. Advanced Materials. 37(15). e2418053–e2418053. 21 indexed citations breakdown →
7.
Fang, Mingzhu, Boyu Su, Shilin Zhang, et al.. (2025). Engineered Intelligent Microenvironment Responsive Prodrug Conjugates Navigated by Bioinspired Lipoproteins for Reversing Liver Fibrosis. Small Methods. 9(7). e2402247–e2402247. 1 indexed citations
8.
Guo, Yun, et al.. (2025). Polymer-engineered PROTAC nanovehicles amplify synergistic effects with temozolomide by BRD4 degradation. Biomaterials Science. 13(18). 5001–5016.
9.
You, Haoyu, Shuo Geng, Mohammad Imani, et al.. (2024). Recent advances in biomimetic strategies for the immunotherapy of glioblastoma. Biomaterials. 311. 122694–122694. 17 indexed citations
10.
Yu, Lina, Yu Song, Jie Bi, et al.. (2024). Exploring the potent hydrolytic activity of chitosan-cerium complex microspheres resin for organophosphorus pesticide degradation. Heliyon. 10(13). e33642–e33642. 2 indexed citations
11.
Zhou, Zheng, Keying Li, Yun Guo, et al.. (2023). ROS/Electro Dual-Reactive Nanogel for Targeting Epileptic Foci to Remodel Aberrant Circuits and Inflammatory Microenvironment. ACS Nano. 17(8). 7847–7864. 29 indexed citations
12.
Li, Xu‐Wen, Tao Sun, & Chen Jiang. (2023). Intelligent Delivery Systems in Tumor Metabolism Regulation: Exploring the Path Ahead. Advanced Materials. 36(11). e2309582–e2309582. 21 indexed citations
13.
Chu, Yongchao, et al.. (2022). Physicochemical Characterization and Pharmacological Evaluation of Novel Propofol Micelles with Low-Lipid and Low-Free Propofol. Pharmaceutics. 14(2). 414–414. 5 indexed citations
15.
Chu, Yongchao, Yifan Luo, Boyu Su, et al.. (2022). A neutrophil-biomimic platform for eradicating metastatic breast cancer stem-like cells by redox microenvironment modulation and hypoxia-triggered differentiation therapy. Acta Pharmaceutica Sinica B. 13(1). 298–314. 34 indexed citations
16.
Liu, Peixin, Tongyu Zhang, Qinjun Chen, et al.. (2021). Biomimetic Dendrimer–Peptide Conjugates for Early Multi‐Target Therapy of Alzheimer's Disease by Inflammatory Microenvironment Modulation. Advanced Materials. 33(26). e2100746–e2100746. 115 indexed citations
17.
Sun, Tao, Guang‐Ping Zhang, Zhongyuan Guo, et al.. (2020). Co-delivery of Cu(I) chelator and chemotherapeutics as a new strategy for tumor theranostic. Journal of Controlled Release. 321. 483–496. 36 indexed citations
18.
Jiang, Chen, Lu Liu, Xiaodong Li, et al.. (2017). Separation and purification of hypocholesterolaemic peptides from whey protein and their stability under simulated gastrointestinal digestion. International Journal of Dairy Technology. 71(2). 460–468. 11 indexed citations
19.
Li, Xiaodong, et al.. (2013). Relationship between membrane damage, leakage of intracellular compounds, and inactivation of Escherichia coli treated by pressurized CO2. Journal of Basic Microbiology. 54(8). 858–865. 38 indexed citations
20.
Jiang, Chen. (2003). Effect of cellulase on chitosan hydrolysis. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026